Modulation of sphingosine receptors influences circadian pattern of cardiac autonomic regulation

Fingolimod is an oral sphingosine‐1‐phospate (S1P) receptor modulator for the treatment of relapsing‐remitting multiple sclerosis (RRMS). In addition to therapeutic effects on lymphoid and neural tissue, fingolimod influences cardiovascular system by specific S1P‐receptor modulation. The effects of...

Descripción completa

Detalles Bibliográficos
Autores principales: Simula, Sakari, Laitinen, Tomi P., Laitinen, Tiina M., Hartikainen, Päivi, Hartikainen, Juha E. K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5027338/
https://www.ncbi.nlm.nih.gov/pubmed/27624686
http://dx.doi.org/10.14814/phy2.12870

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5027338/
https://www.ncbi.nlm.nih.gov/pubmed/27624686
http://dx.doi.org/10.14814/phy2.12870

Ejemplares similares